1. PB2102: PHASE 2 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLAMOTAMAB COMBINED WITH TAFASITAMAB (TAFA) + LENALIDOMIDE (LEN) VS TAFA+LEN IN RELAPSED OR REFRACTORY DLBCL. (23rd June 2022) Authors: Michot, J.-M.; Koh, Y.; Lee, P.; Jin, J.; Clynes, R.; Kye, S.; Chiarella, M.; Patel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: PHASE 3 VERONA STUDY ASSESSING THE SAFETY AND EFFICACY OF VENETOCLAX WITH AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED HIGHER-RISK MYELODYSPLASTIC SYNDROMES. (September 2021) Authors: Zeidan, A.M.; Garcia, J.; Fenaux, P.; Platzbecker, U.; Miyazaki, Y.; Xiao, Z.; Zhou, Y.; Naqvi, K.; Kye, S.; Manero, G. Garcia Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗